Global Nursing Education 2023 stocks perception into the current studies and contemporary technologies, which profits sizeable hobby with the large and exuberant presence of Professors, Doctors, and Talented scholar groups and the Primary Health Care meeting`s purpose is to carry together, a multi-disciplinary organization of Scientists and Researchers, Professors, Doctors, Nurses from everywhere in the international are invited cordially to give alternate break-through ideas referring to the and Nursing Care and Primary Health Care promotes top-stage studies and to globalize the best studies in general, as a result making discussions, shows greater the world over aggressive and focusing interest at the current brilliant breakthroughs withinside the area of Global Nursing Education 2023 and Primary Health Care and destiny tendencies and needs.

Read on nursingeducation.nursingconference.com

Throughout history rapid acceleration in the fields of technology and healthcare have often come during humanity’s darkest episodes. The impact of the Covid-19 pandemic is no different. Scientists, innovators, healthcare workers have all risen to the challenge of changing the way they work and finding new solutions to age old problems. They have supported patients and carers in using new technologies. Faster progress is being made in areas such as remote consultations for example. Digital Healthcare Show returns after a three year absence with an agenda that reflects the direction of travel as the country emerges from the pandemic. Our programme harnesses the technological and digital innovations which are emerging and need to be enshrined as best practice in our local health populations. With two days of exceptional educational content, cutting edge case studies and inspirational insight from the innovators, leaders, service users from the UK and beyond, Digital Healthcare Show is a CPD accredited and free to attend event for healthcare professionals.

Read on healthpluscare.co.uk

The Annual Conference brings together employers and diverse stakeholders for a three‐day comprehensive event. With an exciting agenda and top-notch speakers, we’ll connect over Winning Strategies that are Innovative, Impactful and Inclusive. This year’s conference will feature experts and industry leaders sharing the latest in health care cost and delivery, global benefits, well-being, leave and flexibility, health equity, mental health and innovation.

Join us for one-of-a-kind networking and sessions addressing:

• strategies you need to deliver affordable and inclusive health care benefits;
• well-being programs that provide outcomes that matter; and
• a 2023 lens on leave and flexibility

Read on businessgrouphealth.org

For the past 25 years EBD Group has been passionate about facilitating global partnering around in the life sciences community.
Over 14 years ago we brought our focus to China with the launch of ChinaBio Partnering Forum which grew to be the largest life sciences partnering event in China.
With an eye to further expand opportunities for partnering in the region we're excited to launch Asia Bio Partnering Forum in April 2023 in Singapore.
With this inaugural edition we hope to bring together 750 leading executives from around the world, and host more than 3,000 partnering meetings to connect leaders from academia, start-up, and scale-up biotech companies with forward-thinking investors and pharma companies. Along with world-class workshops and panels, innovative company presentations, active exhibition and a variety of networking opportunities make this event an unrivalled forum for companies across the biotech value chain to meet and do business.
EBD Group is thrilled to welcome you to this "must-attend" partnering event with the focus of engaging with the largest network of potential partners to accelerate your cross-border strategies and expand your reach into the Asia market.

Read on go.evvnt.com

In the first major survey since the pandemic, the AACD 2022 State of the Industry Survey includes new findings on popular cosmetic procedures, practice revenues, demographics, and other considerations that can inform owners, associates, suppliers, and more. See how esthetic dentistry has been affected and what we can expect ahead.

Read on aacd.com

Several high-profile partnerships between pharma and AI companies have materialized recently, but with commercial validation of approaches taking place, improving technologies will expedite this process. The AI Driven Drug Discovery Summit Europe will highlight key approaches to implementing novel AI technologies to expanding datasets. With this landscape rapidly evolving, the need to determine where and how AI can most add value has never been stronger. By uniting leaders from pharma, biotech, AI-technology companies and academia, this forum allows you to create a clear strategic vision and ambition regarding the use of AI to optimise drug discovery. This executive event reveals the latest technology upgrading the day-to-day tool kit of drug developers and data scientists spanning the pharmaceutical landscape. Understand how you can harness cutting-edge tools that provide discoverable, accessible, and transformable data analytics to guide your workflow, reducing costs, and informing decisions. Meet senior experts from start-ups to pharmaceutical giants and unlock the full potential of AI/ML platforms that are reshaping drug design, optimisation, and screening. Find out how to upgrade your presence and platform your AI services – based on your objectives we can create custom bespoke packages designed specifically for you.

Read on aidrugdevelopmentsummiteu.com

Microbiology remains an essential tool in reducing microbial growth in the manufacture of pharmaceuticals, to detect and eliminate microorganisms that would pose a risk to patients and jeopardise product batches.

Ensuring the sterility of the finished product continues to be one of the most critical aspects of drug development, however an array of factors is also sustaining new growth and transformation in this field. The regulatory landscape is changing, firstly with the preparation of Annex I, in addition to increasing requirements pertaining to data integrity. 

 Read on go.evvnt.com

Microbiology remains an essential tool in reducing microbial growth in the manufacture of pharmaceuticals, to detect and eliminate microorganisms that would pose a risk to patients and jeopardise product batches.

Ensuring the sterility of the finished product continues to be one of the most critical aspects of drug development, however an array of factors is also sustaining new growth and transformation in this field. The regulatory landscape is changing, firstly with the preparation of Annex I, in addition to increasing requirements pertaining to data integrity. Light is being shed on recent product recalls for mould contamination, and infection outbreaks serve as a reminder to pay more attention to these overlooked organisms, as well as considerations towards container closure integrity testing which is being increasingly deployed to block microbe movement.

On top of this, the developing integration of automation and robotics into the manufacturing pipeline, as well as the increased need for more rapid microbiology methods brought about in part by the surge in ATMPs, are all highlighting the necessity of the field in Pharma.

This industry is ever expanding, join our leading experts at the 6th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA to discuss and analyse the latest advances and challenges surrounding Pharmaceutical Microbiology. Network with the industry professionals, discuss revisions in regulatory and guidance documents, and gain a deeper insights.

Read on go.evvnt.com

Accelerating Biomarker-Driven Drugs into Clinical Trials Whilst Strategising Your CDx Development, IVDR Compliance and Commercialisation Path to Improve Clinical Decision-Making and Patient Outcomes

The 13th Clinical Biomarkers and CDx Europe 2023 returns as the premier European forum for end-to-end discussions, actionable insights, and partnership development to guide biomarker discovery and companion diagnostics (CDx) development programmes as they progress toward commercialisation.

Read on go.evvnt.com

The World Oncology Cell Therapy Congress is the only annual meeting bringing together drug developers, investors, solution providers and clinicians whose purpose is to deliver safe and effective adoptive cell therapy products to clinical implementation.  For 2023, we have revamped and repositioned the schedule to reflect the dynamic research environment of the cell therapy field.  Enjoy an exclusive pre-event evening networking session centred around overcoming barriers to patient access and facilitating clinical distribution of transformative cell therapy products. 

Our on-stage talks, panels and Q&As will come under the following themes:  

• Breakthroughs and Pipeline Advancements 
• New Cell Therapy Platforms and Enabling Technologies 
• Manufacturing at Scale and Commercialization 
• Pre-event evening expanding into Cell Therapy Access 

Read on oncocelltherapy.com